ClinVar Miner

Submissions for variant NM_004168.4(SDHA):c.1772C>T (p.Ala591Val)

gnomAD frequency: 0.00001  dbSNP: rs367621815
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000555083 SCV000651406 uncertain significance Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 2024-12-23 criteria provided, single submitter clinical testing This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 591 of the SDHA protein (p.Ala591Val). This variant is present in population databases (rs367621815, gnomAD 0.004%). This missense change has been observed in individual(s) with head and neck paraganglioma (PMID: 30050099). ClinVar contains an entry for this variant (Variation ID: 472355). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SDHA protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV001013062 SCV001173599 uncertain significance Hereditary cancer-predisposing syndrome 2023-09-08 criteria provided, single submitter clinical testing The p.A591V variant (also known as c.1772C>T), located in coding exon 13 of the SDHA gene, results from a C to T substitution at nucleotide position 1772. The alanine at codon 591 is replaced by valine, an amino acid with similar properties. This variant has been identified in a patient with a head and neck paraganglioma from a cohort of 391 paraganglioma and/or pheochromocytoma patients (Richter S et al. Genet Med, 2019 03;21:705-717).This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein RCV002252166 SCV002523975 uncertain significance See cases 2021-04-08 criteria provided, single submitter clinical testing ACMG classification criteria: PP3
Baylor Genetics RCV003476309 SCV004202397 uncertain significance Dilated cardiomyopathy 1GG 2023-10-09 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.